These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16981190)

  • 21. [Incremental cost effectiveness of multifocal cataract surgery].
    Pagel N; Dick HB; Krummenauer F
    Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Modelling of the costs of productivity losses due to smoking in Germany for the year 2005].
    Prenzler A; Mittendorf T; von der Schulenburg JM
    Gesundheitswesen; 2007 Nov; 69(11):635-43. PubMed ID: 18080936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of demographic changes on health care expenditure in Germany: an analysis considering the expenditures of decedents].
    Gandjour A; Ihle P; Schubert I
    Gesundheitswesen; 2008 Feb; 70(2):77-80. PubMed ID: 18348096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the socio-economic relevance of glaucoma].
    Grüb M; Rohrbach JM
    Klin Monbl Augenheilkd; 2006 Oct; 223(10):793-5. PubMed ID: 17063419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands.
    Douven R; Katona K; T Schut F; Shestalova V
    Eur J Health Econ; 2017 Nov; 18(8):1047-1064. PubMed ID: 28243775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Europe and central Asia's great post-communist social health insurance experiment: Aggregate impacts on health sector outcomes.
    Wagstaff A; Moreno-Serra R
    J Health Econ; 2009 Mar; 28(2):322-40. PubMed ID: 19059663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk adjustment and risk selection in Europe: 6 years later.
    van de Ven WP; Beck K; Van de Voorde C; Wasem J; Zmora I
    Health Policy; 2007 Oct; 83(2-3):162-79. PubMed ID: 17270311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influences of market competition on dental care utilization under the global budget payment system.
    Tsai WC; Kung PT; Chang WC
    Community Dent Oral Epidemiol; 2007 Dec; 35(6):459-64. PubMed ID: 18039287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Financing in knee arthroplasty: a benchmarking analysis.
    Effenberger H; Rehart S; Zumstein MD; Schuh A
    Arch Orthop Trauma Surg; 2008 Dec; 128(12):1349-56. PubMed ID: 18309508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Socioeconomic burden of hip fractures in Germany].
    Weyler EJ; Gandjour A
    Gesundheitswesen; 2007 Nov; 69(11):601-6. PubMed ID: 18080931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Economic evaluation of medically occupationally orientated rehabilitation in patients with musculoskeletal disorders--a cost-benefit analysis from the perspective of the German statutory pension insurance scheme].
    Streibelt M; Blume C; Thren K; Müller-Fahrnow W
    Rehabilitation (Stuttg); 2008 Jun; 47(3):150-7. PubMed ID: 18553245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Corner stones of health care reform discussion: "factually little has changed"].
    Jürgen W
    Pflege Z; 2006 Sep; 59(9):571-3. PubMed ID: 17009800
    [No Abstract]   [Full Text] [Related]  

  • 36. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.
    Li X; Guh D; Lacaille D; Esdaile J; Anis AH
    Health Policy; 2007 Aug; 82(3):340-7. PubMed ID: 17134787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An experiment with regulated competition and individual mandates for universal health care: the new Dutch health insurance system.
    Rosenau PV; Lako CJ
    J Health Polit Policy Law; 2008 Dec; 33(6):1031-55. PubMed ID: 19038869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The demand for healthcare under Taiwan's national health insurance: a count data model approach.
    Lin YH; Chen WY
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):13-22. PubMed ID: 19371173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-evidence-based policy: how effective is China's new cooperative medical scheme in reducing medical impoverishment?
    Yip W; Hsiao WC
    Soc Sci Med; 2009 Jan; 68(2):201-9. PubMed ID: 19019519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferences and choices for care and health insurance.
    van den Berg B; Van Dommelen P; Stam P; Laske-Aldershof T; Buchmueller T; Schut FT
    Soc Sci Med; 2008 Jun; 66(12):2448-59. PubMed ID: 18400349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.